Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings has reported Operating Leases for 8 years, with the latest figure at $307000.0 in Q3 2025.

• On a quarterly basis, Operating Leases fell 85.01% year-over-year to $307000.0 in Q3 2025; TTM through Sep 2025 was $307000.0, a 85.01% decrease from a year earlier, with the FY2024 full-year figure at $1.6 million, down 49.58% from the prior year.
• Operating Leases was $307000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $761000.0 in the prior quarter.
• The five-year high for Operating Leases was $7.9 million in Q1 2021, with the low at $307000.0 in Q3 2025.
• Average Operating Leases over 5 years is $3.9 million, with a median of $4.0 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Operating Leases slipped 8.64% in 2021, then slumped 85.01% in 2025.
• Over 5 years, Operating Leases stood at $6.0 million in 2021, then decreased by 21.5% to $4.7 million in 2022, then plunged by 30.72% to $3.2 million in 2023, then slumped by 49.58% to $1.6 million in 2024, then plunged by 81.2% to $307000.0 in 2025.
• The last three Operating Leases figures came in at $307000.0 (Q3 2025), $761000.0 (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.